After returning from Chen Guangming's hometown, he went back to his own house to find his mother. Pen ~ fun ~ pavilion www.biquge.info

Qin Lu still needed to continue treatment, so he followed the gentle family back to the provincial capital, and Zhang Shi took his wife and children to his father-in-law's house. The others returned to Shenhai together.

After staying in Shenhai for two years, and in the Chinese New Year's Eve, Zhu Xiaojun returned to his parents' house in Pengzhou.

In the eyes of parents, no matter how old a child grows up, he is always a child. Although Zhu Xiaojun is already a Ben San person, at home, he can't enjoy the treatment of adults at all.

Want to cook? I'm sorry, you're too young to do it at all.

Want to mop the floor? I'm sorry, you're too young to drag clean.

Think...... It's useless to think about anything, and my parents don't let me do it at all, and the only thing I can do is play.

Five days after this happy day, on the fourth night of the Lunar New Year, a news report quietly appeared on an online media. At first, the news did not attract many people's attention, but when I woke up the next day, I found that this news actually occupied the headline position of major online media.

A college student named Wei Zexi died of synovial sarcoma after receiving immune cell therapy in a hospital in Tianjing.

Synovial sarcoma is a relatively malignant tumor, which is more common in young people, but the incidence is not high, and an oncologist in a small hospital may not see a single case of this in his life. Synovial sarcoma is characterized by rapid progression of the disease and will first invade the bone and joint at the primary site of the tumor, causing impaired mobility.

At the same time, synovial sarcoma is not very sensitive to radiation and chemotherapy drugs, so it can cause recurrence or metastasis in the short term after surgery.

Just like this college student surnamed Wei, in the two years after the onset of the disease, due to frequent recurrence and metastasis, he has undergone several surgeries.

It wasn't until he could no longer accept surgery that he found the hospital in Tianjing through Du Niang's search engine.

Any situation that seems to be accidental has its inevitability.

The immune cell department of Tianjing Hospital uses a relatively cross-border department name, called XX Tumor Biological Therapy Center. As everyone knows, the scope of tumor biological therapy is quite large, and immune cell therapy is only a branch of biological therapy. But these did not affect the bidding marketing of this department in Du Niang.

Du Niang is a dominant company in China, and any institution, as long as it can afford to pay money, can rank high in Du Niang's search engine. After Tang Weixing founded Tang's Medical Group, he completely got rid of the past business ideas, began to be pragmatic, and began to attach importance to medical heritage. However, his fellow villagers did not have his kind of vision, and still used all kinds of fancy marketing methods as the core, and all kinds of dazzling services as the means, fooling the patients to come, and then gently raised the big knife and slaughtered it fiercely.

The patient surnamed Wei found this hospital through Du Niang's bidding, and was then fooled by the doctors of the immune cell therapy department of this hospital.

The news reports of this incident in the media are all pointed at Du Niang and those descendants of Tang Weixing, so after Zhu Xiaojun read these reports, he did not take it seriously.

But Zhang Shi was very nervous and called Zhu Xiaojun directly.

"Saw the news? It's that Wei Jersey. ”

"See, another unlucky guy, you say, why are there so many mentally retarded people? If you don't believe anything, you have to believe in advertising! ”

"Yes, this medical advertisement is very harmful, Wei Zexi is not the first, and it is definitely not the last."

"Okay, for the New Year, don't always mention these unhappy things."

"I'm afraid...... I'm afraid that after the New Year, there will be even more unhappy things. ”

"What do you mean?"

"I'm worried that the immune cell therapy industry will be devastated. Xiaojun, you are paying attention, now the media's guidance has been linked to the specialty of immune cell therapy. ”

"So what? Real gold is not afraid of fire, the effect of immune cell therapy is clearly there, how many patients have benefited from it? ”

"Alas...... How do you say that? In our country, as long as those in power are willing, the black will become white, and the white will easily become black. Now there are a lot of clowns who have jumped the beam and shouted that CIK or DC-CIK are all technologies that have been eliminated in the United States. ”

"Grass, do these grandsons know how to do it?"

"I definitely don't understand, just because I don't understand, they dare to be so arrogant!"

Zhu Xiaojun was speechless.

CIK is a kind of immune cell, the full name in Chinese is cytokine-induced killer cells, this technology did originate in the United States, and similar technologies that came out at the same time as CIK are NK cells (natural killer cells).

Whether it's CIK or NK, these techniques require the patient's own peripheral blood to extract the mononuclear cells from them for laboratory culture. In the United States, the Food and Drug Administration is the only agency that governs such technologies, and this agency lacks flexibility and has always treated immune cells with drug requirements.

Obviously, the one-to-one production method of immune cell therapy cannot meet the requirements of drug production, so in the United States, various immune cell technologies basically cannot obtain marketing approval.

If you want to develop, you can only rely on the state's scientific research funds.

Everyone is rushing to engage in CIK or NK, and it is obviously impossible for everyone to get the national scientific research fund, so the people behind have to be flexible and study some new immune cells on the basis of CIK.

So, a few years later, CIK was naturally forgotten by the medical research community.

The reason for the oblivion is not that it has no clinical efficacy or that the efficacy is not good, but that the subject has not been awarded the National Scientific Research Fund.

Although China started this project much later than the United States, it has developed very quickly because of the appropriate policies. To this day, many of his colleagues in the United States will recommend his patients to come to our country for immune cell therapy. Moreover, several medical experts engaged in immune cells in China have published clinical research reports on CIK in internationally renowned medical journals, and its superior clinical effect has attracted a group of peers in the United States.

But the facts are so pale in the face of public opinion.

Chinese people who are accustomed to listening to conspiracy theories were fooled by the so-called experts who jumped off the beam and clowns, and decided that CIK was the obsolete technology of the United States, so in the next few days, this media storm ruthlessly involved the technology industry of immune cell therapy.